scholarly journals Impact of Platelet Reactivity to Adenosine Diphosphate Before Implantation of Drug-Eluting Stents on Subsequent Adverse Cardiac Events in Patients With Stable Angina

2012 ◽  
Vol 76 (3) ◽  
pp. 641-649 ◽  
Author(s):  
Chikaaki Motoda ◽  
Hironori Ueda ◽  
Yasuhiko Hayashi ◽  
Mamoru Toyofuku ◽  
Tomokazu Okimoto ◽  
...  
Keyword(s):  
Stable Angina ◽  
Platelet Reactivity ◽  
Adenosine Diphosphate ◽  
Drug Eluting Stents ◽  
Cardiac Events ◽  
Adverse Cardiac Events ◽  
Drug Eluting

Abstract 2520: Drug-Eluting Stents for the Treatment of Chronic Total Occlusion: A Comparison with Sirolimus, Paclitaxel, Zotarolimus, EPC Capture and Everolimus-Eluting Stent: Multicenter Registry in Asia

Circulation ◽  
2008 ◽  
Vol 118 (suppl_18) ◽  
Author(s):  
Sunao Nakamura ◽  
Shotaro Nakamura ◽  
Hisao Ogawa ◽  
Jang-Ho Bae ◽  
Yeo Hans Cahyadi ◽  
...  
Keyword(s):  
Chronic Total Occlusion ◽  
High Volume ◽  
Clinical Results ◽  
Target Lesion ◽  
Drug Eluting Stents ◽  
Cardiac Events ◽  
Total Occlusion ◽  
Angiographic Restenosis ◽  
Adverse Cardiac Events ◽  
Drug Eluting

The aim of this study is to compare the safety and efficacy of Sirolimus (SES), Paclitaxel (PES), Zotarolimus (ZES), EPC capture (ECS) and Everolimus-eluting stent (EES) on the outcome of patients with chronic total occlusion (CTO). A prospective analysis of 1149 patients with 1183 CTOs (396 SES, 526 PES, 177 ZES, 41 ECS, 43 EES) in five high volume Asian centers after successful recanalization of CTO was performed. The study endpoints were 30 days and 9 months major adverse cardiac events (MACE), 9 months angiographic restenosis and target lesion revascularization (TLR). See table for clinical results. The use of drug-eluting stents in patients with CTO was safe with low acute complication. Patients treated with SES and EES showed lesser rate of restenosis compared with other drug-eluting stents.

The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents

2009 ◽  
Vol 157 (5) ◽  
pp. 899-907 ◽  
Author(s):  
Michelle J. Butler ◽  
David Eccleston ◽  
David J. Clark ◽  
Andrew E. Ajani ◽  
Nick Andrianopoulos ◽  
...  
Keyword(s):  
Major Adverse Cardiac Events ◽  
Drug Eluting Stents ◽  
Cardiac Events ◽  
Late Mortality ◽  
Adverse Cardiac Events ◽  
Drug Eluting

scholarly journals High On-Treatment Platelet Reactivity Predicts Cardiac Events in Patients with Drug-Eluting Stents

2013 ◽  
Vol 100 (3) ◽  
Author(s):  
Aline Sterque Villacorta ◽  
Humberto Villacorta Junior ◽  
Marcos J. S. Batista ◽  
Renato Villela Gomes ◽  
Luiz Augusto Macedo ◽  
...  
Keyword(s):  
Platelet Reactivity ◽  
Drug Eluting Stents ◽  
Cardiac Events ◽  
Drug Eluting
Sign in / Sign up

Export Citation Format

Share Document